Efficacy and Safety of Peptide Vaccine in Prevention of SARS-CoV-2 Infection: Prospective Study among Healthcare Professionals

Voprosy Sovremennoj Pediatrii

Firuza Ch. Shakhtakhtinskaya¹  Marina V. Fedoseenko²  Arevaluis M. Selvyan²  Snezhana D. Timoshkova²  Margarita A. Soloshenko²  Elena V. Melekhina²  Khadizhat G. Omarova³  Zhanna B. Ponezheva⁴  Denis V. Usenko⁵  Tatiana A. Kaliuzhnaia⁶  Aleksandr V. Gorelov⁶  Antonina A. Ploskireva⁶  Leyla S. Namazova-Baranova⁶  Ilina Z. Mustafina⁶  Svetlana V. Tolstova⁶  Tatiana E. Privalova⁶  Albina A. Melnikova⁶ 

[1] Belgorod National Research University;Pirogov Russian National Research Medical University;Central Research Institute of Epidemiology of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing;Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing;Pirogov Russian National Research Medical University;Research Institute of Pediatrics and Children’s Health in “Central Clinical Hospital of the Russian Academy of Sciences”;

关键词: coronavirus disease;    covid-19;    vaccination;    peptide vaccine;    prevention;   

DOI  :  10.15690/vsp.v21i2.2386

来源: DOAJ

【 摘 要 】

The pandemic caused by the new coronavirus infection remains the topical health issue and constitutes serious threat to the entire world. Nowadays, active immunization against new type of coronavirus infection continues in Russian Federation and in all other countries. Vaccination is the crucial component in comprehensive program for COVID-19 prevention and control. Mass immunization of population can prevent both admissions and hospitalization in conditions of high incidence of COVID-19 and thereby reduce the burden on the health system. Despite the remaining complications in combating the SARS-CoV-2 pandemic, preventive vaccination is by far the most effective method for protection against this infection Clinical studies on the efficacy of various preventive vaccinations in different regions of the world are extremely relevant especially under conditions of the emergency use authorization for vaccines against new coronavirus infection, the changing epidemiological situation, and the wide variability of different types of vaccines. All countries will need continuously updated data on vaccine efficacy to address new challenges such as weakening post-vaccine protection, new SARS-CoV-2 strains, and need for other preventive measures to mitigate the pandemic.

【 授权许可】

Unknown